Table 1.
n | 435 |
Gender | |
Women | 361 (83) |
Men | 74 (17) |
Age (years) | 54 (42–63) |
Diagnosis | |
Nontoxic goiter | 135 (31) |
Toxic nodular goiter | 98 (23) |
Graves’ hyperthyroidism | 73 (17) |
Graves’ orbitopathy (GO) | 25 (6) |
Autoimmune hypothyroidism | 86 (20) |
Other thyroid diagnoses | 18 (4) |
Disease duration (months) | 0.3 (0–4) |
Treatment instituted | |
Levothyroxine | 111 (26) |
Antithyroid medication | 86 (20) |
Aspiration of thyroid cyst | 4 (1) |
Glucocorticoid pulse therapy of GO | 2 (0) |
Other immunosuppressive treatment of GO | 4 (1) |
Hemithyroidectomy | 64 (15) |
Total thyroidectomy | 37 (9) |
Radioactive iodine | 127 (29) |
Data are expressed as number (percentage) or median (interquartile range (Q1–Q3)).